蜜桃传媒app

McGill.ca / Vue d'ensemble / All Courses

EPIB 654 Pharmacoepidemiology 4 (2 unit茅s)

important

Nota : Ceci est la version 2019鈥�2020 de l'annuaire 茅lectronique. Veuillez mettre 脿 jour l'ann茅e dans la barre d'adresse de votre navigateur pour une version plus r茅cente de cette page, ou .

Offered by: 脡pid茅miologie et biostat. (Facult茅 de m茅decine et des sciences de la sant茅)

Administered by: 脡tudes sup茅rieures et recherch

Vue d'ensemble

脡pid茅miologie et biostatistiques : The utility of epidemiological techniques for the assessment of drug benefits after their marketing is presented. The course is composed of four parts: (i) methodology of Phase IV studies (efficacy and effectiveness studies); (ii) measurement of quality of life; (iii) evaluation of the economic impact of drugs; (iv) assessment of the effects of drugs and vaccines on the public health system.

Terms: This course is not scheduled for the 2019-2020 academic year.

Instructors: There are no professors associated with this course for the 2019-2020 academic year.

  • Offered only in Summer term.

  • Prerequisite(s): EPIB 601 and EPIB 607 or permission of instructor.

  • Due to the intensive nature of this course, the standard add/drop and withdrawal deadlines do not apply. Add/drop is the first lecture day and withdrawal is the second lecture day.

Back to top